CDKN1A and hepatocellular carcinoma: They showed that CDKN1A, TP53I3, and PPM1D were upregulated by AL158206.1. Contrasting these findings, another work examining lncRNAs involved in the epithelial-mesenchymal-transition, associated with metastasis, identified AL158206.1 as one of four lncRNAs having the strongest negative impact on the survival of patients undergoing drug treatment of hepatocellular carcinoma (61).